SEP 01, 2021 4:57 PM PDT

It Seems Not All COVID-19 Patients Develop Antibodies

WRITTEN BY: Carmen Leitch

It's been generally assumed that people who get infected with SARS-COV-2 will develop antibodies to the virus, which causes COVID-19. Preliminary research appeared to confirm that when antibodies to the virus could be identified in anyone that had been found to have a SARS-CoV-2 infection through an RT-PCR test. Most studies suggested that the human body would start generating antibodies against the virus from one to three weeks after they started having COVID-19 symptoms.

This scanning electron microscope image shows SARS-CoV-2 (round gold particles) emerging from the surface of a cell cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. Image captured and colorized at Rocky Mountain Laboratories in Hamilton, Montana./  Credit: NIAID

But several recent reports have found that not everyone who gets infected has detectable antibodies. When someone gets infected but does not develop antibodies, it's said that they don't seroconvert. Several research studies from different countries have come to this conclusion. A report from Israel determined that five percent of COVID-19 patients that had gotten a positive test result from a nasal swab did not seroconvert. In Germany, scientists found that 85 percent of people that had contact with SARS-CoV-2-positive individuals did not develop antibodies to the virus.

A new study by the Centers for Disease Control and Prevention (CDC) has suggested that younger people and those with a lower detectable level of virus by RT-PCR are less likely to seroconvert.

The CDC study assessed 72 volunteers that had all gotten positive COVID-19 RT-PCR tests. Only 2 of these volunteers (3 percent) had not gotten any symptoms. When the others in the study had been sick, 18 percent had a mild case of COVID-19, 67 percent were moderately ill, and 12 percent had been severely sick. All of these individuals had recovered, and had not had any symptoms for three weeks or more before their blood samples were collected for the study.

The researchers found that the individuals with lower levels of the virus when they were tested were less likely to produce a lot of antibodies - RT-PCR can provide some insight into the level of virus that's carried by a person. The researchers acknowledge that false positives were possible, but unlikely. RT-PCR tests can also be very sensitive, and find a positive case even when little to no symptoms are present. The research concluded that not everyone that had been sick enough to go to a clinic for care produced antibodies; moderate or severe illness was not a guarantee that antibodies would be detectable.

The CDC noted that antibody measurements may not be reliable for answering some questions. For example, antibody levels don't always tell us whether someone is immune; a person may not have antibodies in their blood but their body may still be capable of producing them. Seroconverted people and non-seroconverted people may also have different antibody responses to a vaccine; seropositive people seem to have a stronger response to the first dose of an mRNA vaccine, but not the second. It may also not be possible to know whether a person that tested positive for COVID-19 but did not produce detectable antibodies is protected from future infections. That could help explain why some people seem to get COVID-19 multiple times.

The study also highlights the high degree of variability in the response to SARS-CoV-2 exposure. A recent report that examined a cohort of Israeli patients and vaccinated people suggested that people who had been sick with COVID-19 were slightly better protected from reinfection than people who'd only been vaccinated. However, only small numbers of either group had gotten re-infected or gotten COVID-19 after vaccination, showing that both still protect most people against SARS-CoV-2 infection. We don't yet know how that could change in the future, and new variants may still emerge in those who continue to be infected.

The CDC study has noted that people who have been diagnosed with COVID-19 by RT-PCR but who have not gotten sick should not assume that they are protected from the virus.


Sources: CDC, Emerging Infectious Diseases

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 22, 2021
Immunology
Healthy, Young People Are Getting Reinfected With COVID
APR 22, 2021
Healthy, Young People Are Getting Reinfected With COVID
If you’re young and healthy and you’ve had COVID, your body will produce protective antibodies that guard yo ...
APR 27, 2021
Drug Discovery & Development
Natural Remedy Better than Steroids For COVID-19 Smell Loss
APR 27, 2021
Natural Remedy Better than Steroids For COVID-19 Smell Loss
An international group of olfactory experts have recommended against the use of steroid treatments for loss of smell rel ...
MAY 12, 2021
Immunology
Illuminating the COVID-19 Disease Profile Puzzle
MAY 12, 2021
Illuminating the COVID-19 Disease Profile Puzzle
Teams of science experts from numerous disciplines have been collecting data on SARS-CoV-2 for over a year to understand ...
JUN 03, 2021
Immunology
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
JUN 03, 2021
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
Nanobodies are small fragments of monoclonal antibodies that from a therapeutic perspective are more stable and cheaper ...
AUG 19, 2021
Immunology
Insights Into the Interplay Between COVID and the Nasal Microbiome
AUG 19, 2021
Insights Into the Interplay Between COVID and the Nasal Microbiome
There is a spectrum of COVID symptom severity: some recover after experiencing nothing more than a mild cough, while oth ...
AUG 18, 2021
Cannabis Sciences
Cannabis Use Disorder Linked to COVID Hospitalization
AUG 18, 2021
Cannabis Use Disorder Linked to COVID Hospitalization
People with a genetic predisposition to cannabis use disorder (CUD) are more likely to require hospitalization after con ...
Loading Comments...